18-77250552-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001480.4(GALR1):āc.4G>Cā(p.Glu2Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000393 in 1,526,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001480.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GALR1 | NM_001480.4 | c.4G>C | p.Glu2Gln | missense_variant | 1/3 | ENST00000299727.5 | |
LOC124904329 | XR_007066422.1 | n.604+296C>G | intron_variant, non_coding_transcript_variant | ||||
GALR1 | XM_017025691.2 | c.4G>C | p.Glu2Gln | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GALR1 | ENST00000299727.5 | c.4G>C | p.Glu2Gln | missense_variant | 1/3 | 1 | NM_001480.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152144Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.00000291 AC: 4AN: 1374096Hom.: 0 Cov.: 37 AF XY: 0.00000443 AC XY: 3AN XY: 676962
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152144Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2023 | The c.4G>C (p.E2Q) alteration is located in exon 1 (coding exon 1) of the GALR1 gene. This alteration results from a G to C substitution at nucleotide position 4, causing the glutamic acid (E) at amino acid position 2 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at